(lp0
S'Ampio Pharmaceuticals Provides Corporate Update Yahoo Finance - 16 hours ago ENGLEWOOD, Colo., March 20, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, announced an&nbsp;...Ampio Pharmaceuticals, Inc.  in-depth technical analysis - Post AnalystInvestors Spotlight: Ampio Pharmaceuticals, Inc.  - Is stories'
p1
aS'Ampio Pharmaceuticals - Running On Fumes Seeking Alpha - Feb 1, 2017 My interest in Ampio Pharmaceuticals Inc.,  was established several days ago during the Optometric Leaders Forum in Montreal, Canada.Ampio Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 01 - Equities.com'
p2
aS'Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire  - Aug 29, 2016 ENGLEWOOD, Colo., Aug. 29, 2016 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.  today announced that it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of 5,000,000&nbsp;...'
p3
aS'Buy or Sell Great Panther Silver Limited  Ampio Pharmaceuticals, Inc ... Rives Journal - 13 hours ago Great Panther Silver Limited  shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm.'
p4
aS'Ampio Pharmaceuticals Inc. AMPE  Wall Street Journal - May 20, 2011 Ampio Pharmaceuticals Inc. AMPE . search. View All companies. AT CLOSE 4:02 PM EST 03/10/17. $0.80 USD; 0.00 -0.12%.'
p5
aS'Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA ... PR Newswire  - Oct 14, 2015 ENGLEWOOD, Colo., Oct. 14, 2015 /PRNewswire/ - Ampio Pharmaceuticals, Inc.  today announced that Ampio met with the Division of the Transplant and Ophthalmology Products of the FDA to discuss the results of the OptimEyes&nbsp;...Ampio Pharma updates on path to FDA approval for DME drug Optina - The Pharma Letter '
p6
aS'Ampio Pharmaceuticals  Stock Tanks Today after Treatment Fails To Reach ... TheStreet.com - Apr 20, 2015 NEW YORK  -- Ampio Pharmaceuticals  shares are down 65.76% to $2.71 in trading on Monday after the biopharmaceutical company announced that the multiple injection STRIDE study for pain reliever Ampion did not reach its primary&nbsp;...AMPIO Announces Ampion STRIDE Study Results - PR Newswire '
p7
aS'Ampio Pharmaceuticals Inc.  Plunges 5.48% on March 08 Equities.com - Mar 8, 2017 Ampio Pharmaceuticals Inc.  had a rough trading day for Wednesday March 08 as shares tumbled 5.48%, or a loss of $-0.0452 per share, to close at $0.78.Would You Buy Ampio Pharmaceuticals, Inc.  On These Analyst Ratings? - Fiscal Standard'
p8
aS'AMPIO PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... Market Exclusive - Mar 13, 2017 Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.'
p9
aS'Sell Your Ampio Pharmaceuticals Shares Now: AMPE Is Setting Up For A Secondary Seeking Alpha  - Jan 27, 2015 Two of the four executives at Ampio have direct ties to Isolagen, an aesthetic procedure company that was accused by shareholders of malfeasance and ultimately went bankrupt.'
p10
a.